Cell line · CVCL_2119
MOLM-13
Cancer cell line, Homo sapiens. Adult acute monocytic leukemia. 131 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Download JSON
Cite this record
ConductScience Library. MOLM-13. Cell lines, record CVCL_2119. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_2119
On this page
Cell line
As Cellosaurus gives it.
- Name
- MOLM-13
- Accession
- CVCL_2119
- RRID
- RRID:CVCL_2119
- Synonyms
- MOLM13, Molm13, Molm 13
- Species
- Homo sapiens (Human)
- Sex
- Male
- Age at sampling
- 20Y
- Category
- Cancer cell line
- Diseases
- Adult acute monocytic leukemia (NCIt C8263); Myelodysplastic syndrome (NCIt C3247); Acute monoblastic/monocytic leukemia (ORDO Orphanet_514)
- Derived from
- Peripheral blood (in situ)
- Entry created
- 2012-04-04
- Entry updated
- 2026-06-25
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers131
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| BCLAF1 links RNA splicing to ATF4-dependent metabolic adaptation in acute myeloid leukemia. | Sci Adv | 2026 | Its Methods give the RRID and name the line | PubMed | |
| IL10RB-AS1 promotes pro-caspase-1-dependent pyroptosis via regulating the oligomerization and nucleation of CARD8 C-terminal domain to suppress acute myeloid leukemia. | Cell Death Dis | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Pharmacologically Targeting DHODH-Dependent Pyrimidine Metabolism with HSA-Conjugated BRQ Suppresses Leukemogenesis. | Cancers (Basel) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Greatwall kinase regulates acute myeloid leukaemia cell division through a non-canonical mechanism. | EMBO Rep | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Very Long Chain Fatty Acid Synthesis is a Targetable Dependency in RAS Pathway Mutant Leukemia. | Blood Cancer Discov | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Impact of IL-21 on CAR T-cell manufacturing: phenotypic, metabolic, and functional outcomes. | Front Immunol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Intracellular iron homeostasis-regulated epigenetic reprogramming contributes to -7/del(7q) leukemia. | Nat Commun | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Integrative multi-omics, machine learning, and experimental validation reveal that TPM1 suppresses M2 macrophage polarization and enhances chemosensitivity in acute myeloid leukemia. | Cell Biol Toxicol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Localized heme sensing through a ternary molecular glue. | bioRxiv | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Nanobody-Engineered CLL-1 CAR T Cells: Optimizing Tumor-Specific Cytotoxicity and Minimizing Off-Tumor Toxicity. | Cancer Res Commun | 2026 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 131
See all 131 papersRelatives12
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Derived from it | EDITGENE MOLM-13-Cas9 | CVCL_F5QZ | Cell lines | |
| Derived from it | EDITGENE MOLM-13-CopGFP | CVCL_F6CH | Cell lines | |
| Derived from it | EDITGENE MOLM-13-FLUC | CVCL_F5V0 | Cell lines | |
| Derived from it | HyCyte MOLM-13 KO-hADGRE2 | CVCL_F1S3 | Cell lines | |
| Derived from it | HyCyte MOLM-13 KO-hPTEN | CVCL_F1S4 | Cell lines | |
| Derived from it | MOLM-13-RES | CVCL_D779 | Cell lines | |
| Derived from it | MOLM-13/AZA | CVCL_C0WJ | Cell lines | |
| Derived from it | MOLM-13/DAC | CVCL_C0WK | Cell lines | |
| Derived from it | MOLM/AZA-1 | CVCL_WI20 | Cell lines | |
| Derived from it | MOLM/DEC-5 | CVCL_WI21 | Cell lines |
1 to 10 of 12
See all 12 relativesCell banks4
| Cell bank | Catalog number | Status | Source |
|---|---|---|---|
| AddexBio | C0003003/60 | Cellosaurus | |
| DSMZ | ACC-554 | DSMZ | |
| EDITGENE | EDC00312 | EDITGENE | |
| JCRB | JCRB1810 | JCRB |
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_2119
GET https://conductscience.org/api/cell-lines/v1/CVCL_2119/papers?page=2